5,748 Shares in Johnson & Johnson (NYSE:JNJ) Purchased by Peak Retirement Planning Inc.

Peak Retirement Planning Inc. bought a new position in Johnson & Johnson (NYSE:JNJ - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,748 shares of the company's stock, valued at approximately $833,000.

A number of other institutional investors have also recently added to or reduced their stakes in JNJ. Tallon Kerry Patrick acquired a new stake in Johnson & Johnson in the fourth quarter worth approximately $290,000. Capital & Planning LLC increased its holdings in shares of Johnson & Johnson by 13.6% in the fourth quarter. Capital & Planning LLC now owns 1,528 shares of the company's stock valued at $221,000 after buying an additional 183 shares in the last quarter. Mitchell & Pahl Private Wealth LLC increased its holdings in shares of Johnson & Johnson by 4.2% in the fourth quarter. Mitchell & Pahl Private Wealth LLC now owns 18,174 shares of the company's stock valued at $2,628,000 after buying an additional 739 shares in the last quarter. Sugar Maple Asset Management LLC bought a new position in shares of Johnson & Johnson in the fourth quarter valued at $60,000. Finally, Hamlin Capital Management LLC increased its holdings in shares of Johnson & Johnson by 9.6% in the fourth quarter. Hamlin Capital Management LLC now owns 1,076,740 shares of the company's stock valued at $155,718,000 after buying an additional 94,147 shares in the last quarter. 69.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have issued reports on JNJ shares. Morgan Stanley upped their price target on Johnson & Johnson from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Wednesday, April 16th. Raymond James cut their target price on shares of Johnson & Johnson from $165.00 to $162.00 and set an "outperform" rating on the stock in a research note on Monday, April 14th. Benchmark raised shares of Johnson & Johnson to a "strong-buy" rating in a research note on Thursday, April 24th. The Goldman Sachs Group raised shares of Johnson & Johnson from a "neutral" rating to a "buy" rating and boosted their target price for the company from $157.00 to $172.00 in a research note on Wednesday, April 9th. Finally, Leerink Partnrs downgraded shares of Johnson & Johnson from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, May 13th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $170.88.

Johnson & Johnson Stock Performance

Shares of Johnson & Johnson stock traded up $1.61 during trading on Tuesday, reaching $153.25. The company's stock had a trading volume of 6,977,625 shares, compared to its average volume of 7,961,204. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.86 and a current ratio of 1.11. The business's fifty day moving average price is $155.05 and its 200-day moving average price is $153.65. The firm has a market cap of $368.73 billion, a price-to-earnings ratio of 23.05, a price-to-earnings-growth ratio of 2.56 and a beta of 0.42. Johnson & Johnson has a one year low of $140.68 and a one year high of $169.99.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings data on Tuesday, April 15th. The company reported $2.77 EPS for the quarter, topping analysts' consensus estimates of $2.59 by $0.18. The business had revenue of $21.89 billion for the quarter, compared to analyst estimates of $21.65 billion. Johnson & Johnson had a return on equity of 34.24% and a net margin of 18.20%. As a group, equities research analysts predict that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 27th will be given a dividend of $1.30 per share. The ex-dividend date is Tuesday, May 27th. This is an increase from Johnson & Johnson's previous quarterly dividend of $1.24. This represents a $5.20 dividend on an annualized basis and a yield of 3.39%. Johnson & Johnson's dividend payout ratio (DPR) is 57.84%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.